JP2024516187A5 - - Google Patents

Info

Publication number
JP2024516187A5
JP2024516187A5 JP2023565251A JP2023565251A JP2024516187A5 JP 2024516187 A5 JP2024516187 A5 JP 2024516187A5 JP 2023565251 A JP2023565251 A JP 2023565251A JP 2023565251 A JP2023565251 A JP 2023565251A JP 2024516187 A5 JP2024516187 A5 JP 2024516187A5
Authority
JP
Japan
Prior art keywords
cells
hspcs
hematopoietic stem
subject
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565251A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516187A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/061666 external-priority patent/WO2022233767A1/en
Publication of JP2024516187A publication Critical patent/JP2024516187A/ja
Publication of JP2024516187A5 publication Critical patent/JP2024516187A5/ja
Pending legal-status Critical Current

Links

JP2023565251A 2021-05-05 2022-05-02 幹細胞機能を向上させるためのウロリチン Pending JP2024516187A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21172290 2021-05-05
EP21172290.5 2021-05-05
PCT/EP2022/061666 WO2022233767A1 (en) 2021-05-05 2022-05-02 Urolithin for increasing stem cell function

Publications (2)

Publication Number Publication Date
JP2024516187A JP2024516187A (ja) 2024-04-12
JP2024516187A5 true JP2024516187A5 (https=) 2025-05-16

Family

ID=75825544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565251A Pending JP2024516187A (ja) 2021-05-05 2022-05-02 幹細胞機能を向上させるためのウロリチン

Country Status (8)

Country Link
US (1) US20240228966A1 (https=)
EP (1) EP4333832A1 (https=)
JP (1) JP2024516187A (https=)
CN (1) CN117202903A (https=)
AU (1) AU2022270331A1 (https=)
BR (1) BR112023022224A2 (https=)
CA (1) CA3213384A1 (https=)
WO (1) WO2022233767A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998005635A1 (en) 1996-08-07 1998-02-12 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
WO2019163176A1 (ja) * 2018-02-21 2019-08-29 株式会社ダイセル ウロリチン類を含有する破骨細胞分化抑制剤
JP7557374B2 (ja) * 2018-04-30 2024-09-27 アマゼンティス エスアー 免疫増強剤としてのウロリチンa
JP7677893B2 (ja) * 2019-01-18 2025-05-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 幹細胞機能を向上させるための薬剤及び方法

Similar Documents

Publication Publication Date Title
JP2023060299A (ja) 敗血症の治療のための、ワルトンジェリーから取得された間葉系幹細胞
Zheng et al. Ecological insights into hematopoiesis regulation: unraveling the influence of gut microbiota
AU2018212530B2 (en) Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant
Nabarrete et al. Brazilian nutritional consensus in hematopoietic stem cell transplantation: children and adolescents
Park et al. Hematopoietic effect of deer antler extract fermented by Bacillus subtilis on murine marrow cells
JP2024516187A5 (https=)
US12551523B2 (en) HIF-1 activator
JP2023543149A5 (https=)
JP2023542640A5 (https=)
JP2023542640A (ja) 幹細胞機能を向上させるための組成物及び方法
JP6851060B2 (ja) 造血幹細胞の分化促進剤
JP3970916B2 (ja) ナチュラルキラー細胞の増殖剤及び増殖方法
TWI801753B (zh) 提升免疫力及抑制腫瘤之營養製品
Myakotnykh et al. Comparative analysis of different geroprotective methods
US20040076618A1 (en) Placental preparation having antitumor activity
WO2015020567A1 (en) Laminaria angustata-based product for enhancing regeneration and proliferation of cells, method of producing and use the same
KR102890705B1 (ko) 자연살해세포 배양용 배지 조성물 및 이를 이용한 자연살해세포 배양방법
US20100129329A1 (en) METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
AU2001282436B2 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
Salva et al. Can immunobiotics beneficially modulate hemato-immune responses in immunocompromised hosts
TWI745609B (zh) 具抗氧化活性之組合物
JP2018030787A (ja) 幹細胞の未分化状態維持剤及び増殖促進剤
CN119564735A (zh) 一种增强免疫功能的组合物及应用
Drapeau ENDOGENOUS STEM CELL MOBILIZATION A NEW PARADIGM
FR2659013A1 (fr) Nouvelle composition pharmaceutique agissant sur la division des cellules.